
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.950 | 100.950 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.082 | 17.550 |
Price to Book | 2.061 | 3.768 |
Price to Sales | 3.602 | 4.926 |
Price to Cash Flow | 8.190 | 15.596 |
Dividend Yield | 0.347 | 0.540 |
5 Years Earnings Growth | 3.109 | 13.034 |
Number of long holdings: 34
Number of short holdings: 26
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Exelixis | US30161Q1040 | 9.96 | 43.03 | +1.56% | |
Ionis Pharma | US4622221004 | 9.64 | 35.29 | +0.14% | |
Biogen | US09062X1037 | 7.89 | 133.13 | +2.12% | |
Crispr Therapeutics | CH0334081137 | 4.98 | 41.84 | +8.48% | |
Jazz Pharma | IE00B4Q5ZN47 | 4.74 | 111.13 | +2.14% | |
Gilead | US3755581036 | 4.71 | 112.46 | +1.81% | |
Biomarin Pharma | US09061G1013 | 4.71 | 56.65 | +2.50% | |
Alnylam | US02043Q1076 | 4.65 | 300.83 | -2.33% | |
Bavarian Nordic | DK0015998017 | 4.50 | 181.0 | +0.28% | |
Denali Therapeutics | US24823R1059 | 4.44 | 14.70 | +3.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class A | 58.3M | -11.40 | -9.82 | -0.00 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review